Evidence map›Paper›PMID 25479769›Full record

ArticleHealth and quality of life outcomes2014

The validity of the EQ-5D-3L items: an investigation with type 2 diabetes patients from six European countries.

Uwe Konerding, Sylvia G Elkhuizen, Raquel Faubel, Paul Forte, Tomi Malmström, Elpida Pavi, M F Bas Janssen

Registry-linked trialAbstract read
In one paragraph

Article in Health and quality of life outcomes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05031299 (Lifestyle-related Early Detection and Intervention for Older Adults & Elderly at Risk for Metabolic Syndrome), which is not on this map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05031299 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Lifestyle-related Early Detection and Intervention for Older Adults & Elderly at Risk for Metabolic Syndrome: GATEKEEPER

TypeinterventionalSponsorHarokopio UniversityRan2021 to 2022Enrolled960ConditionsMetabolic SyndromeArmsStandard care, Health-promotion application for self-management, Wearables and devices
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2018
    Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Uwe KonerdingTrimberg Research Academy, University of Bamberg, Bamberg, D-96045, Germany. uwe.konerding@uni-bamberg.de.
Sylvia G ElkhuizenInstitute of Health Policy & Management, Erasmus University Rotterdam, PO Box 1738, Rotterdam, DR, 3000, The Netherlands. elkhuizen@bmg.eur.nl.
Raquel FaubelJoint Research Unit in Biomedical Engineering, IIS La Fe- Universitat Politècnica de València, Bulevar sur s/n, 46026, Valencia, Spain. rfaubel@itaca.upv.es.
Paul ForteThe Balance of Care Group, 39a Cleveland Road, London, N1 3ES, UK. paul@paul40.demon.co.uk.
Tomi MalmströmDepartment of Industrial Engineering and Management, Aalto University, PO Box 15500, Espoo, Aalto, 00076, Finland. tomi.malmstrom@aalto.fi.
Elpida PaviDepartment of Health Economics, National School of Public Health, 196 Alexandras Ave, 115 21, Athens, Greece. epavi@esdy.edu.gr.
M F Bas JanssenDepartment of Psychiatry, Section Medical Psychology & Psychotherapy, Erasmus MC, PO Box 2040, CA, 3000, Rotterdam, The Netherlands. mf.bas.janssen@googlemail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost previous studies concerning the validity of the EQ-5D-3L items refer to applications of only a single language version of the EQ-5D-3L in only one country. Therefore, there is little information concerning the extent to which the results can be generalised across different language versions and/or different countries. Here the validity of the EQ-5D-3L items is investigated for six different language versions in six different countries.

methodsData came from 1341 type 2 diabetes patients (England: 289; Finland: 177; Germany: 255; Greece: 165; the Netherlands: 354; Spain: 101). The relationships of the five EQ-5D-3L items with seven different test variables (age, gender, education, previous stroke, problems with heart, problems with lower extremities, problems with eyes), were analysed for each combination of item and test variable. For each combination two logistic regression models with the dichotomised EQ-5D-3L item as dependent variable were computed. The first model contained the test variable and dummy coded countries as independent variables, the second model additionally the terms for the interaction between country and test variable. Statistically significant better fit of the second model was taken as evidence for country specific differences regarding the relationship. When such differences could be attributed mainly to one country the analyses were repeated without the data from this country. Validity was investigated with the remaining data using results of the first models.

resultsDue to lack of variation in the Spanish data only 31 of the originally intended 35 interaction tests could be performed. Only three of these yielded a significant result. In all three cases the Spanish data deviated most. Without the Spanish data only 1 of the 35 interaction tests yielded a significant result. With 3 exceptions, the tendency of reporting problems increased with age, female gender, lower education, previous stroke, heart problems, problems with lower extremities and problems with eyes for all EQ-5D-3L items.

conclusionThe results concerning the European Spanish version are ambiguous. However, the items of the English, Finnish, German, Greek and Dutch versions of the EQ-5D-3L relate in substantially the same way to the test variables. Mostly, these relationships indicate the items' validity.

Indexed as

Activities of Daily LivingMobility LimitationQuality of LifeAgedDiabetes ComplicationsDiabetes Mellitus, Type 2EnglandEuropeFemaleFinlandGermanyGreeceHumansLogistic ModelsMaleMiddle Aged

Identifiers

PMID25479769
PMCPMC4263046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.